Publications


Molecular characterization of breast cancer CTCs associated with brain metastasis;
Boral, D, Vishnoi, M, Liu, HN, Yin, W, Sprouse, ML, Scamardo, A, Hong, DS, Tan, TZ, Thiery, JP, Chang, JC & Marchetti, D 2017, Nature Communications, vol 8, no. 1, 196. DOI:

The isolation and characterization of CTC subsets related to breast cancer dormancy;
Vishnoi, M, Peddibhotla, S, Yin, W, Scamardo, AT, George, GC, Hong, DS & Marchetti, D 2015, Scientific reports, vol 5, 17533. DOI:

Oncogenic role of Merlin/NF2 in glioblastoma;
Guerrero, PA, Yin, W, Camacho, L & Marchetti, D 2015, Oncogene, vol 34, no. 20, pp. 2621-30. DOI:

Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes;
Caruana, I, Savoldo, B, Hoyos, V, Weber, G, Liu, H, Kim, ES, Ittmann, MM, Marchetti, D & Dotti, G 2015, Nature Medicine, vol 21, no. 5, pp. 524-529. DOI:

Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer;
Zhang, L, Ngo, JA, Wetzel, MD & Marchetti, D 2015, Neoplasia (United States), vol 17, no. 1, pp. 101-113. DOI:

MicroRNA and Protein Profiling of Brain Metastasis Competent Cell-Derived Exosomes;
Camacho, L, Guerrero, P & Marchetti, D 2013, PLoS ONE, vol 8, no. 9, e73790. DOI:

The identification and characterization of breast cancer CTCs competent for brain metastasis;
Zhang, L, Ridgway, LD, Wetzel, MD, Ngo, J, Yin, W, Kumar, D, Goodman, JC, Groves, MD & Marchetti, D 2013, Science Translational Medicine, vol 5, no. 180, 180ra48. DOI:

Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells;
Ridgway, LD, Wetzel, MD, Ngo, JA, Erdreich-Epstein, A & Marchetti, D 2012, Molecular Cancer Research, vol 10, no. 6, pp. 689-702. DOI:

Selection of brain metastasis-initiating breast cancer cells determined by growth on hard agar;
Guo, L, Fan, D, Zhang, F, Price, JE, Lee, JS, Marchetti, D, Fidler, IJ & Langley, RR 2011, American Journal of Pathology, vol 178, no. 5, pp. 2357-2366. DOI:

Heparanase modulates Shh and Wnt3a signaling in human medulloblastoma cells;
Ridgway, LD, Wetzel, MD & Marchetti, D 2011, Experimental and Therapeutic Medicine, vol 2, no. 2, pp. 229-237. DOI: